HURA
TuHURA Biosciences Inc.

15,761
Loading...
Loading...
News
all
press releases
Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline
The merger brings together two biotech firms aiming to tackle immune resistance in cancer, with plans to advance programs targeting Merkel Cell Carcinoma.
Stocktwits·3mo ago
News Placeholder
More News
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of...
PR Newswire·9mo ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of...
PR Newswire·9mo ago
News Placeholder
SHAREHOLDER ALERT: The MandA Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc. - HURA
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc. - HURA SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences...
PR Newswire·9mo ago
News Placeholder
HURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of TuHURA Biosciences, Inc. (NASDAQ: HURA) and Kineta, Inc. is fair to TuHURA shareholders. Halper Sadeh encourages...
Business Wire·9mo ago

Latest HURA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.